GlassScriptPhysician profile
Robert W Einhorn
NPI 1144487737
$1,018.81
in general payments reported to CMS, 2019-2025
25 companies · $70.92 in 2025
The $70.92 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $34.18 · 2021: $109 · 2022: $266 · 2023: $326 · 2024: $90.77 · 2025: $70.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $470 · Travel and Lodging: $18.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.69 |
| Travel and Lodging | $18.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $208.95 | 2022-2025 | Allomatrix, Citrefix, Flexband |
| Medtronic, INC. | $105.11 | 2023 | Hawkone, Closurefast |
| Abbvie INC. | $84.90 | 2023-2024 | |
| Smith+Nephew, INC. | $75.53 | 2022-2023 | Regranex, Iodosorb Ointment 40g USA, Collagenase Santyl |
| Advanced Oxygen Therapy INC. | $50.32 | 2021-2024 | Topical Oxygen Chamber For Extremities |
| Orthofix Medical, INC. | $44.67 | 2022 | |
| Integra Lifesciences Corporation | $34.18 | 2020 | |
| Nevro Corp. | $34.00 | 2022 | |
| Bioventus LLC | $33.21 | 2019-2021 | |
| Solventum Corporation | $31.77 | 2025 | Activ.A.C. |
| Organogenesis INC. | $31.42 | 2019 | |
| Paragon 28, INC. | $30.41 | 2023 | Hammertube |
| Abbott Laboratories | $24.99 | 2021 | |
| Baxter Healthcare | $24.12 | 2019 | |
| Treace Medical Concepts, INC. | $24.10 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $23.10 | 2021 | |
| Paratek Pharmaceuticals, INC. | $22.67 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $21.18 | 2023 | Seglentis |
| Horizon Therapeutics Plc | $19.09 | 2022 | |
| Polarityte, INC. | $18.65 | 2019 | |
| Averitas Pharma INC. | $18.53 | 2023 | Qutenza |
| Musculoskeletal Transplant Foundation INC. | $18.29 | 2023 | |
| Tactile Systems Technology INC | $17.55 | 2019 | |
| Merck Sharp & Dohme LLC | $13.39 | 2019 | |
| Heron Therapeutics, INC. | $8.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Einhorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.